AstraZeneca and Hadasit, the commercial arm and technology transfer company of Israel’s Hadassah University Hospitals have agreed to identify, evaluate, and jointly develop new treatments for several diseases, primarily focused on cancer, respiratory diseases, and diabetes.
http://jewishbusinessnews.com/2013/09/24/british-astrazeneca-and-israeli-hadasit-launch-drug-discovery-alliance/